Cargando…
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
Alzheimer's disease (AD) is an intractable progressive neurodegenerative disease characterized by cognitive decline and dementia. An inflammatory neurodegenerative pathway, involving Caspase-1 activation, is associated with human age-dependent cognitive impairment and several classical AD brain...
Autores principales: | Flores, Joseph, Noël, Anastasia, Foveau, Bénédicte, Lynham, Jeffrey, Lecrux, Clotilde, LeBlanc, Andréa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156230/ https://www.ncbi.nlm.nih.gov/pubmed/30254377 http://dx.doi.org/10.1038/s41467-018-06449-x |
Ejemplares similares
-
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
por: Flores, Joseph, et al.
Publicado: (2020) -
Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
por: Flores, Joseph, et al.
Publicado: (2021) -
Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits
por: Noël, Anastasia, et al.
Publicado: (2021) -
Caspase vinyl sulfone small molecule inhibitors prevent axonal degeneration in human neurons and reverse cognitive impairment in Caspase-6-overexpressing mice
por: Pakavathkumar, Prateep, et al.
Publicado: (2017) -
Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment
por: Foveau, Benedicte, et al.
Publicado: (2016)